ArticlePloS one2026
EffAtt-LungNet: An attention-guided EfficientNet framework for three-class lung histopathology classification.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents EffAtt-LungNet, an attention-guided deep learning framework for three-class lung histopathology classification. The model combines an EfficientNetB3 backbone with the Convolutional Block Attention Module (CBAM) to refine features and improve discrimination among benign lung tissue, lung adenocarcinoma, and lung squamous cell carcinoma. Experiments used the publicly released LC25000 lung subset, which contains 15,000 images across three classes and was itself produced by augmenting a smaller collection of underlying histopathology images. We generated 10,500 additional fixed variants, creating a balanced working corpus of 25,500 images with training, validation, and test partitions of 15,300, 2,550, and 7,650 images. EffAtt-LungNet reached 99.86% accuracy, 99.86% precision, 99.86% recall, 99.86% F1 score, and 0.9997 AUC on the image-level test partition. Performance was stable across five random seeds (mean accuracy 99.86±0.02%), and paired errors differed from those of the EfficientNetB3 backbone (McNemar's test, χ2=47.27, p < 0.001). Because pre-augmentation source identifiers for the released LC25000 images were unavailable, independence at the earliest source-image level could not be confirmed. The results therefore represent internal tile-level benchmark performance and require validation on independent, non-augmented, multi-centre datasets before any translational or clinical claim can be made.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.